Amboy Street Ventures is the world's first venture capital fund focused on Women's Health and Sexual Wellbeing for all genders. The firm invests in the Seed and Series A rounds of startups across maternal health, menopause, fertility, hormonal health, abortion access, LGBTQ+ health, and sexual health and pleasure.
33% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 2 prior). Their most common stage is series-a (67% of deals). Average disclosed round size is $8.9M (across 12 rounds with reported amounts).
Portfolio
14
Fund Size
$20M
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
15 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Nest Health | Series A | $12.5M | Oct 2025 |
 Millie | Series A | $12M | Feb 2025 |
 Granata Bio | Series A | $15M | Jan 2025 |
 Millie | Series A | $12M | Jan 2025 |
 Gesynta Pharma | Series B | — | Jan 2025 |
 Evvy | Series A | — | Sep 2023 |
 HerMD | Series A | $18M | Jul 2023 |
 Dame | Series A | — | Sep 2022 |
 Aunt Flow | Series A | $8.5M | Apr 2022 |
| Dame | Seed | $4M | Jan 2021 |
| DDame Products | Series A | $7M | — |
| TTestmate Health | Seed | $6M | — |
 Allswell | Pre-Seed | $1.3M | — |
 JUNIPER GENOMICS | Seed | $4.6M | — |
 Hey Jane | Series A | $6.1M | — |
Top Co-Investors
Joyance Partners4 shared
Flybridge Capital Partners3 shared
Ingeborg Investments3 shared
Foreground Capital3 shared
Techstars2 shared
Echo2 shared
Larsen Ventures2 shared
Listen2 shared
RH Capital2 shared
The Helm2 shared
TMV2 shared
BBG Ventures2 shared
Pivotal Ventures2 shared
LearnStart2 shared
Harlem Capital1 shared
CityRock Venture Partners1 shared
Precursor Ventures1 shared
JLL Spark1 shared
8VC1 shared
The Blue Venture Fund1 shared
Last updated: 20 October 2026